Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02417883

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02417883
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02417883. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-04 (registry gives no type); primary completion 2016-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease
Acronym
FST-IFTA
Intervention (Drug)
Furosemide
Lead sponsor
Instituto Nacional de Cardiologia Ignacio Chavez (class: other)

Record details

Record id
cardio:ct-nct02417883
Content hash
ceb24bcbd22f69d72b640d669eb7c2cc6048430b86893ea1992ac274c87fe7a2